Comparison of a Tobacco-Specific Carcinogen in Tobacco Cigarette, Electronic Cigarette, and Dual Users

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2023 May 16

PMID 37191844

Authors

Jae-Woo Lee

Sukil Kim

Affiliations

Soon will be listed here.

Abstract

Background: 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) is known as a lung carcinogen. The objective of this study was to investigate associations of urine NNAL concentrations and smoking status.

Methods: This was a cross-sectionally designed study based on data from the 2016-2018 Korean National Health and Nutrition Examination Survey. A total of 2,845 participants were classified into past-smoker, electronic cigarette (e-cigar) only, dual-user, and cigarette only smoker groups. All sampling and weight variables were stratified and analysis was conducted accounting for the complex sampling design. Analysis of covariance was used to compare the geometric mean of urine NNAL concentrations and log-transformed urine NNAL level among smoking status with weighted survey design. Post hoc paired comparisons with Bonferroni adjustment was performed according to smoking status.

Results: The estimated geometric mean concentrations of urine NNAL were 1.974 ± 0.091, 14.349 ± 5.218, 89.002 ± 11.444, and 117.597 ± 5.459 pg/mL in past-smoker, e-cigar only, dual-user, and cigarette only smoker groups, respectively. After fully adjusting, log-transformed urine NNAL level was significantly different among groups ( < 0.001). Compared with the past-smoker group, e-cigar only, dual-user, and cigarette only smoker groups showed significantly higher log-transformed urine NNAL concentrations in post hoc test (all < 0.05).

Conclusion: E-cigar only, dual-user, and cigarette only smoker groups showed significantly higher geometric mean concentrations of urine NNAL than the past-smoker group. Conventional cigarette, dual users, and e-cigar users can potentially show harmful health effects from NNAL.

References

Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P . Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013; 8(3):e57987. PMC: 3603976. DOI: 10.1371/journal.pone.0057987. View

Hecht S, Stepanov I, Carmella S . Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines. Acc Chem Res. 2015; 49(1):106-14. PMC: 5154679. DOI: 10.1021/acs.accounts.5b00472. View

Goniewicz M, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J . Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2013; 23(2):133-9. PMC: 4154473. DOI: 10.1136/tobaccocontrol-2012-050859. View

Kim Y . The Korea National Health and Nutrition Examination Survey (KNHANES): current status and challenges. Epidemiol Health. 2014; 36:e2014002. PMC: 4017741. DOI: 10.4178/epih/e2014002. View

Carlson E, Upadhyaya P, Villalta P, Ma B, Hecht S . Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite.... Chem Res Toxicol. 2018; 31(5):358-370. PMC: 5995121. DOI: 10.1021/acs.chemrestox.8b00056. View

Hecht S, Carmella S, Murphy S, Akerkar S, Brunnemann K, Hoffmann D . A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 1993; 329(21):1543-6. DOI: 10.1056/NEJM199311183292105. View

Farsalinos K, Voudris V, Poulas K . Are metals emitted from electronic cigarettes a reason for health concern? A risk-assessment analysis of currently available literature. Int J Environ Res Public Health. 2015; 12(5):5215-32. PMC: 4454963. DOI: 10.3390/ijerph120505215. View

Wagner K, Flora J, Melvin M, Avery K, Ballentine R, Brown A . An evaluation of electronic cigarette formulations and aerosols for harmful and potentially harmful constituents (HPHCs) typically derived from combustion. Regul Toxicol Pharmacol. 2018; 95:153-160. DOI: 10.1016/j.yrtph.2018.03.012. View

Hecht S . Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998; 11(6):559-603. DOI: 10.1021/tx980005y. View

10.

Kovi R, Johnson C, Balbo S, Hecht S, OSullivan M . Metastasis to the F344 Rat Pancreas from Lung Cancer Induced by 4-(Methylnitrosamino)- 1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol, Constituents of Tobacco Products. Toxicol Pathol. 2018; 46(2):184-192. PMC: 5825274. DOI: 10.1177/0192623317751573. View

11.

Coleman B, Rostron B, Johnson S, Ambrose B, Pearson J, Stanton C . Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014. Tob Control. 2017; 26(e2):e117-e126. PMC: 6693501. DOI: 10.1136/tobaccocontrol-2016-053462. View

12.

Gaur S, Agnihotri R . Health Effects of Trace Metals in Electronic Cigarette Aerosols-a Systematic Review. Biol Trace Elem Res. 2018; 188(2):295-315. DOI: 10.1007/s12011-018-1423-x. View

13.

Benowitz N, Goniewicz M . The regulatory challenge of electronic cigarettes. JAMA. 2013; 310(7):685-6. DOI: 10.1001/jama.2013.109501. View

14.

Margham J, McAdam K, Forster M, Liu C, Wright C, Mariner D . Chemical Composition of Aerosol from an E-Cigarette: A Quantitative Comparison with Cigarette Smoke. Chem Res Toxicol. 2016; 29(10):1662-1678. DOI: 10.1021/acs.chemrestox.6b00188. View

15.

Kasza K, Ambrose B, Conway K, Borek N, Taylor K, Goniewicz M . Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014. N Engl J Med. 2017; 376(4):342-353. PMC: 5317035. DOI: 10.1056/NEJMsa1607538. View

16.

Kiernan E, Click E, Melstrom P, Evans M, Layer M, Weissman D . A Brief Overview of the National Outbreak of e-Cigarette, or Vaping, Product Use-Associated Lung Injury and the Primary Causes. Chest. 2020; 159(1):426-431. DOI: 10.1016/j.chest.2020.07.068. View

17.

Patel D, Davis K, Cox S, Bradfield B, King B, Shafer P . Reasons for current E-cigarette use among U.S. adults. Prev Med. 2016; 93:14-20. PMC: 5316292. DOI: 10.1016/j.ypmed.2016.09.011. View

18.

Kweon S, Kim Y, Jang M, Kim Y, Kim K, Choi S . Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43(1):69-77. PMC: 3937975. DOI: 10.1093/ije/dyt228. View

19.

Kang M, Won Y, Lee J, Jung K, Kim H, Kong H . Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019. Cancer Res Treat. 2022; 54(2):330-344. PMC: 9016309. DOI: 10.4143/crt.2022.128. View

20.

Akopyan G, Bonavida B . Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. Int J Oncol. 2006; 29(4):745-52. View